<PAGE>                                      
                                UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                               ------------------

                                   FORM 10-K

                               ------------------

[X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934


                        SUBURBAN OSTOMY SUPPLY CO., INC.
             (Exact name of registrant as specified in its charter)
 
 Massachusetts                        5047                      04-2675674
(State or other           (Primary Standard Industrial       (I.R.S. Employer
 jurisdiction of           Classification Code Number)      Identification No.)
incorporation or              
 organization)

                              75 October Hill Road
                              Holliston, MA 01746
                                 (508) 429-1000
              (Address, including zip code, and telephone number,
       including area code, of registrant's principal executive offices)

Securities registered pursuant to Section 12(b) of the Act: NONE

Securities registered pursuant to Section 12 (g) of the Act:

         Title of each class           Name of each exchange on which registered
Common Stock, no par value per share                    NASDAQ

         Indicate by check mark whether the registrant: (1) has filed all 
reports required to be filed by Section 13 or 15 (d) of the Securities Exchange
Act of 1934 during the preceeding 12 months and (2) has been subject to such
filing requirements for the past 90 days.   Yes           No   X

         Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy  or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K.  [X]

         The aggregate market value of shares held by non-affiliates of the
registrant as of November 20, 1997 was $55,987,557. 10,538,622 shares of the
Common Stock of Suburban Ostomy Supply Co. Inc., no par value, were outstanding
on November 20, 1997.<PAGE>

<PAGE>                              PART I
ITEM 1. BUSINESS

General

     Suburban Ostomy Supply Co., Inc. ("Suburban" or the "Company") is a 
leading national direct marketing wholesaler of medical supplies and related 
products to the home health care industry.  The Company sells products to 
over 23,000 customers, including: (i) independent providers of home health 
care products (principally home medical equipment dealers, home health 
agencies and local and chain pharmacies); (ii) national home health care 
chains and wholesalers; and (iii) managed care organizations ("MCO's").  
Through its direct sales and marketing programs, the Company markets a com-
prehensive selection of approximately 7,800 SKUs, composed primarily of ostomy, 
incontinence, diabetic and wound care products.  The Company's primary product 
lines fulfill its customers' needs to provide a complete line of products for 
their home health care patients.  The Company believes that its success is 
attributable to the expertise gained from more than 18 years of focus on its 
product lines and its commitment to providing superior service and technical 
support to its customers. Through its product knowledge and ability to effic-
iently process a high volume of orders without a minimum order amount, the 
Company fills an important need in the fragmented and diverse home health care 
industry.

     The Company's first catalog was mailed in 1977, and Suburban was
incorporated as a Massachusetts corporation in 1979 by Herbert P. Gray.

     The Company's executive offices are located at 75 October Hill Road,
Holliston, Massachusetts 01746 and its telephone number is (508) 429-1000.

     The Company has positioned itself as a high volume, cost-effective direct
marketer of home health care products. The Company's direct marketing materials,
particularly its industry-recognized catalog, offer a broad selection of prod-
ucts in an easy to use format, enabling the Company to offer its customers a
single source for the Company's product lines. The Company's 83 experienced,
highly-trained service representatives use the Company's proprietary software
to fill customer orders, explore additional product needs and respond to cus-
tomer inquiries. Suburban provides quick, cost-effective delivery on a national 
basis, enabling the Company to meet the needs of national home health care 
providers and MCO's as well as local independent suppliers.  Its national 
distribution network enables the Company to ship about 91% of its orders on 
the day of receipt, with a product fill rate of about 93%, and to deliver 
product to 94% of the U.S. population within 48 hours.  The Company also 
provides customers with value-added services, such as the Company's Stockless 
Inventory Program in which the Company ships products directly to its cus-
tomers' patients and provides detailed utilization reporting to customers. 
The Stockless Inventory Program is designed to assist customers in reducing 
their inventory levels, controlling costs and managing utilization.

     The Company is committed to meeting the changing needs of manufacturers and
customers in the home health care market. Manufacturers are becoming
increasingly dependent upon wholesalers to help reduce manufacturers' cost by
assuming their small order distribution. The Company achieves volume discounts,
rebates and promotional allowances from manufacturers by providing significant
value added services to its suppliers through marketing support and information

                                       2<PAGE>
<PAGE>

management. Suburban's high degree of service, technical support and outbound
telemarketing complements the manufacturers' continuing product support. In
addition, Suburban's direct marketing expertise enhances the manufacturers'
continuing product support and also enhances the manufacturers' ability to 
introduce new products and sustain ongoing marketing campaigns. With respect 
to customers, cost containment efforts are prompting many of the Company's 
customers to become "one stop shop" suppliers of home health care products. 
Suburban offers customers a comprehensive selection of products that customers 
typically are unable to stock cost effectively because of the relatively low 
volume of sales of such products by these customers. The Company's national 
distribution network and management information systems enable it to fill a 
large quantity of the small and broken case orders typically placed by home 
health care providers and which many other wholesalers have difficulty filling 
efficiently.

     In May 1997, the Company acquired Peiser's Medical Supplies and Services
("Peiser's") which had approximately $17 million in sales in its then most 
recent fiscal year.  The Company paid $8 million in cash and stock.  Peiser's 
is a home health medical supply distribution company that also provides manage-
ment services to the home health market, in particular, supplying home health 
care products on a patient-specific basis to home health agencies and MCO's 
nationwide.  The addition of Peiser's provides the Company with added 
penetration into the home health agency and MCO markets.
 
National Distribution Network

     The Company has seven regional distribution centers located in Holliston,
Massachusetts; Atlanta, Georgia; Dallas, Texas; South Bend, Indiana; Rancho
Cucamonga, California, Santa Fe Springs, California and Broadview, Illinois.
This network enables the Company to meet the needs of national home care chains
and MCO's, as well as local independent suppliers in a quick, cost effective
manner. In addition, the Company's management information systems are designed
to coordinate inventory with order fulfillment so that the Company efficiently
fills orders in any of its seven regional distribution centers.

Sales and Marketing

     The Company's direct marketing program is designed to provide its cus-
tomers with frequent exposure to the Company's comprehensive product cate-
gories on a cost effective basis. The Company's direct marketing program 
consists of the following components: (i) a wholesale catalog for custom 
orders; (ii) a retail catalog for customers to use as a marketing tool; (iii) 
monthly flyers; (iv) frequent fax specials to targeted customer segments; (v) 
package inserts; (vi) general advertising; (vii) trade press literature; and 
(viii) trade show materials.  The Company continually evaluates these direct 
marketing components to arrive at the optimal mix of marketing techniques.

     In fiscal 1997, the Company's marketing staff internally produced over 
one million pieces of direct mail, consisting of catalogs, fliers, trade press 
advertisements and package inserts.  The Company's comprehensive wholesale 
catalog strengthens the Company's position as a leader in its market by serv-
ing as a valuable reference source for its products, facilitating the ordering 
process and providing a complete description of products in a listing of

                                       3<PAGE>
<PAGE>

manufacturers and prices for all ordering quantities.  The Company has also 
developed and maintains a proprietary customer and product database which it 
uses to target its direct mailings.

Products

     The Company supplies approximately 7800 SKUs, primarily in the ostomy,
incontinence, diabetic and wound care categories. These four product categories
accounted for approximately 79.5% of Suburban's net sales for fiscal 1997.

<TABLE>
<CAPTION>
                         Net Sales for     Percentage of Net   
                          Fiscal 1997         Sales for       No. of SKUs at    
Product Categories    (dollars in 000's)     Fiscal 1997      August 30, 1997
------------------     ----------------      -----------      ---------------
<S>                       <C>                  <C>              <C>
Ostomy                    $26,324               27.9%           1,588
Incontinence               21,600               22.9            1,314
Diabetic Care*              9,486               10.0              168
Wound Care                 17,642               18.7            1,489
Other                      19,388               20.5            3,292
                           ------              -----            ----- 
Total                     $94,440              100.0%           7,851
                           ======              =====            ===== 
</TABLE>
---------------------
* Includes Impotence

     Ostomy Products.  Suburban has developed an expertise in the ostomy market
and markets a broad spectrum of related products, primarily one and two piece
ostomy appliances, accessories, adhesives, pastes, skin barriers and odor
control products. Ostomy appliances come in numerous shapes and sizes, including
one-piece and two-piece models, and reusable or disposable systems. Depending on
the manufacturer and the system, patients may replace their ostomy dressing as
frequently as daily, or as infrequently as once per week. In response to its
customers' individual needs and preferences, the Company offers a large number
of SKUs within the ostomy category which the Company believes acts as a barrier
to entry to those competitors unable to stock a complete assortment of those
products on a cost effective basis.

     Incontinence Products.  The Company markets a broad selection of
incontinence and urological products, including disposable and reusable adult
diapers and undergarments, irrigation trays, intermittent and external
catheters, and drainage and leg bags.

     Diabetic Care Products.  The American Diabetes Association estimates that
there are 11.0 million diabetics in the U.S., 1.1 million of whom must test
themselves four to seven times daily to control the potentially degenerative
effects of diabetes.  The diagnostic and monitoring market was expected to 
reach approximately $877 million in 1997.  The Company markets a broad 
selection of products for the treatment of diabetes, including test strips, 
blood-glucose meters, lancets and accessories.

                                       4<PAGE>
<PAGE>
     Wound Care Products.  Based on industry statistics, the Company believes
that the total U.S. market for wound care and related products of the type
marketed by the Company was approximately $400 million in 1996.  Medical studies
show that approximately 1.5 to 4 million patients suffer from chronic, non-
healing wounds costing as much as $50,000 per patient treated.  Wound care
products marketed by the Company include traditional tapes, gauze, bandages and
sponges and advanced dressings such as hydrocolloid, calcium alginates, hydrogel
and transplant dressings. Since wound treatment programs have improved
technologically and become more individualized, the number of SKUs which the
Company carries relating to wound care has increased to 1,489 SKUs at August 30,
1997 versus 634 SKU's at August 31, 1996.

     Other Products.  The Company sells a large assortment of products for 
home health care other than those in its principal four product categories. 
These products are frequently ordered by its customers and include respiratory,
convalescent care, skin care, home diagnostic and enteral feeding products. 
The Company continually evaluates new product categories within the home 
health care market to meet the evolving needs of its customers and to take 
advantage of changes in medical technologies.

Customers

     The Company's three market segments consist of over 23,000 customers,
including: (i) independent suppliers of home health care products, principally
home medical equipment suppliers, home health agencies and local and chain 
pharmacies; (ii) national home health care chains and wholesalers; and (iii) 
MCO's.  Sales to independent suppliers, national home health care chains, 
wholesalers and MCO's accounted for approximately 79.0%, 16.5% and 4.5%, 
respectively, of net sales in fiscal 1997, and 82.4%, 15.5% and 2.0%, 
respectively, of net sales for fiscal 1996.
 
While the number of independent home medical equipment suppliers and phar-
macies continues to decline due to consolidation, the Company continues to 
add new customers in this market. Of Suburban's broad customer base, only 5 
customers accounted for more than 1% of the Company's net sales for fiscal 
1997, and the twenty largest customers accounted for approximately 19.3% and 
18.2% of net sales for fiscal 1997 and 1996, respectively.

Order Entry and Fulfillment; Customer Service and Technical Support

     Order Entry and Fulfillment.  The Company provides a toll-free number and
uses its call center and automated call routing technology to process an
average of 4,075 calls per day between 8:00 a.m. and 7:00 p.m. local time, with
service representatives answering approximately 94% of all calls within thirty
seconds. The Company's 83 service representatives use the Company's proprietary
software to fill customer orders, explore additional product needs and respond
to customer inquiries. Each service representative has access to the customer's
profile, which contains information on product availability, prices, order
history, shipping address and billing information.

     Customer Service and Technical Support.  The Company provides its customers
with a high level of customer service and technical support, the principal bases
of which are accurate and complete order fulfillment and prompt product
delivery. All new service representatives receive at least four weeks of
consecutive, specialized training, two of which precede any customer contact.
Thereafter, service representatives regularly receive weekly sales and product
                                      5<PAGE>
<PAGE>
training. In addition to in-house training, sales representatives regularly 
receive from manufacturers technical training regarding various products.  To 
augment its service representatives, the Company employs two registered nurses, 
including an enterostomal therapist, who are accessible to respond to more 
complex customer inquiries regarding the Company's products.
     
     The Company markets its Stockless Inventory Program to all its customers
pursuant to which it ships products on the customer's behalf directly to the
customer's patients. The transaction is transparent to the patient as only the
names of the Company's customer and the recipient of the product appear in the
shipping materials received. The Stockless Inventory Program also enables both
the Company and the customer to record a sale at the time the order is shipped
by the Company. The Company shipped 14% of its net sales through its Stockless
Inventory Program for fiscal 1997.

     With the Stockless Inventory Program, the Company also provides additional
value-added services for its larger customers, such as detailed reporting with
respect to the patient's payor and clinician as well as the products shipped to
the patient's home.

Management Information Systems

     The Company operates a sophisticated proprietary management information
system that allows centralized management of key functions, including: (i)
accounts receivable and inventory management; (ii) communication links between
distribution centers; (iii) customized customer reporting; (iv) purchasing; (v)
pricing; (vi) order entry and fulfillment; (vii) mail list management; and
(viii) the preparation of daily management reports which provide timely
information regarding key aspects of the business. The system enables the
Company to ship customer orders on a same-day basis and respond to order 
changes and supports a high level of customer service.
     
     In 1997, the Company began modifying its computer system programming to 
process transactions in the year 2000.  Anticipated spending for this modifi-
cation will be expensed as incurred and is not expected to have a significant 
impact on the Company's ongoing results of operations.

Purchasing

     The Company purchases products from 541 manufacturers and regularly
evaluates its relationships and considers alternative suppliers to ensure
competitive costs and product quality. The Company's top ten manufacturers
accounted for approximately 61.9% and 64.6%, of the Company's total purchases
in fiscal 1997 and fiscal 1996, respectively. The Company is able to achieve
volume discounts, rebates and promotional allowances from manufacturers by
providing significant value added services through marketing support and
information management. Purchasing is closely tied to the inventory management
controls of the Company. Due to the Company's effective inventory management,
the Company's inventory write-offs during the last five fiscal years have been
negligible.

Competition

     Suburban faces intense competition from a variety of local, regional and
national wholesalers. In addition to home health care wholesalers, Suburban's
competition includes drug wholesalers and distributors to hospitals and long
                                       
                                       6<PAGE>
<PAGE>

term care distibutors. Most of the Company's products are available from 
several sources, and the Company's customers often have relationships with 
several wholesalers. In response to competitive pressures from current or 
future competitors, the Company may be required to lower selling prices to 
maintain or increase market share.

     The Company competes on the basis of its: (i) order and delivery
capabilities; (ii) product knowledge; (iii) product breadth; (iv) technical
support; (v) customer relationships with service representatives; and (vi)
price. The Company believes that its customers base their purchasing decisions
upon such factors and that the Company competes favorably with respect to each
of these factors. In particular, the Company believes that it differentiates
itself from other wholesalers with which it competes on the basis of a high fill
rate of its product line, knowledgeable service representatives, the Stockless
Inventory Program and its MIS capabilities.

Governmental Regulation

     Suburban is subject to regulation under the Federal Food, Drug and Cosmetic
Act, as well as under certain state regulations, because of its storage and
handling of certain medical devices and products. The amount of sales of
products that are subject to such regulation is not material to the Company's
results of operations. The Company believes that it is in compliance with all
applicable federal and state requirements and that it possesses all licenses and
permits required for the conduct of its business. In addition, certain licenses
and permits of the Company prohibit a change of control without relevant
regulatory approval.

Product Liability Insurance

     The Company maintains product liability insurance of $10.0 million, and is
named as an additional insured under policies maintained by approximately 95% of
its manufacturers whose products represent approximately 98% of the Company's
net sales. While the Company believes that such coverage will be adequate, no
assurance can be given that such coverage will be adequate to cover all future
claims or will be available in adequate amounts or at a reasonable cost or that
such indemnification agreement will provide adequate protection to the Company.

State Sales Tax

     The Company collects sales tax or other similar tax only with respect to
those states in which the Company maintains facilities. Although various other
state agencies have attempted to impose on direct marketers the burden of
collecting state sales taxes on the sale of products shipped to residents of
these states, no state has initiated any action to collect state sales taxes
from the Company. The Company does not believe that state sales tax collection
is material to the Company, in part because substantially all products marketed
by the Company are purchased for resale and in part because a large portion of
its products are exempt from state sales tax.

Proprietary Rights

     The Company holds service marks for the names "Home Health Direct" and
"Patient Care" which it uses in certain of its direct marketing programs.
                                       
                                       7<PAGE>
<PAGE>

Employees

     As of August 30, 1997, the Company had 251 full time employees and 38
part time employees. There are 94 employees within the sales, marketing and
customer service areas, 77 employees within the financial, administrative and
purchasing areas, and 118 employees within the distribution, operations and
MIS areas. The Company considers its employee relations to be good. None of
the Company's employees are covered by a collective bargaining agreement.


ITEM 2. PROPERTIES

Properties

      The Company conducts its operations from seven leased distribution
centers. Note 7 to Consolidated Financial Statements. The Holliston,
Massachusetts location also serves as the Company's corporate headquarters.
The Company's leases include:

<TABLE>
<CAPTION>
                Location           Square Footage     Expiration Date
                --------           --------------     ---------------  
       <S>                             <C>         <C>
       Holliston, MA   (1)             59,500         August 31, 2006
       Atlanta, GA     (1)             48,000          August 4, 2006
       Dallas, TX                      24,000           June 30, 2001
       South Bend, IN  (1)             30,000           July 31, 2003
       Rancho Cucamonga, CA            23,000      September 30, 2000
       Santa Fe Springs, CA            33,500            May 31, 1998
       Broadview, Il                   17,500          April 30, 2002
       Broadview, Il                   19,000         August 31, 1998
</TABLE> 
----------------------
(1) See "Item 13 - Certain Relationships and Related Transactions."
  
 
ITEM 3. LEGAL PROCEEDINGS

     The Company is party to certain claims and litigation in the ordinary
course of business. The Company is not involved in any legal proceeding that it
believes will result, individually or in the aggregate, in a material adverse
effect on its financial condition or results of operations.

                                        
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     There were no matters that were required to be submitted to Stockholders.

                                        8<PAGE>
<PAGE>
 
                                    PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.

     The Company's common stock is traded on the National Association of
Securities Dealers Automated Quotation system (NASDAQ). As of November 20, 
1997 the Company had approximately 1300 shareholders.

The following table sets forth the the range of high and low prices of the
Company's Common Stock as reported on the NASDAQ during each quarter of fiscal 
1997 for which the Company's Common Stock was traded on a public exchange.


COMMON STOCK PRICES
--------------------
Quarter Ended                      Hi Price       Low Price
--------------                     --------       ---------

November 30, 1996*                  $15.75         $10.75 
March 1, 1997                        14.00          10.125
May 31, 1997                         11.75           8.75 
August 30, 1997                      11.25           8.25

* Trading on the Company's Common Stock began on October 10, 1996.


Dividends

     The Company has not paid and does not intend to pay any dividends on its
common stock in the foreseeable future. The Company intends to retain all
earnings for the operation and expansion of its business. The declaration of
payment of future dividends will be at the sole discretion of the Board of
Directors subject to such factors as the Board of Directors may deem relevant,
including future earnings, results of operations, capital requirements, the
general financial condition of the Company, general business conditions and
contractual restrictions (such as those relating to the Company's borrowing
arrangements).



ITEM 6: SELECTED CONSOLIDATED FINANCIAL DATA

     The following Selected Consolidated Financial Data as of and for each
fiscal year in the five year period ended August 30, 1997, have been derived
from the Consolidated Financial Statements. These consolidated financial
statements have been audited by Arthur Andersen LLP, independent public
accountants. The data should be read in conjunction with the Consolidated
Financial Statements and related notes thereto included elsewhere in this 10-K.

                                        9<PAGE>
<PAGE>
                    SELECTED CONSOLIDATED FINANCIAL DATA  
             (In thousands, except per share and operating data)
<TABLE>
<CAPTION>
                                             Fiscal Year Ended (1) 
                               --------------------------------------------------
                               August 30, August 31,  Sept 2,  Sept 3, August 28, 
                                  1997      1996      1995      1994       1993
                               (52 weeks)(52 weeks)(52 weeks)(53 weeks)(52 weeks)
                                --------  --------  --------- --------  --------
<S>                              <C>      <C>       <C>(2)   <C>       <C>
Consolidated Income Statement Data:  
----------------------------------
Net Sales                        $94,440  $72,558   $52,667  $47,311   $42,738 
Cost of Goods Sold                70,615   55,398    39,872   35,599    32,305  
                                  ------   ------    ------   ------    ------
Gross profit                      23,825   17,160    12,795   11,712    10,433 
Operating expenses                14,291    9,689     7,752    7,627     6,991
Depreciation and amortization      1,032      562       266      270       265
Non-recurring executive comp. (3)      -        -         -    2,237     2,111
                                  ------   ------    ------   ------    ------
Operating income                   8,502    6,909     4,777    1,578     1,066
Interest expense                     437    2,653       370        -         -
Other expense (income), net         (127)    (126)     (145)    (132)     (158)
                                  ------   ------    ------   ------    ------
Income before income taxes         8,192    4,382     4,552    1,710     1,224
Provision for income taxes         3,599    1,944       358       88        69
                                  ------   ------    ------   ------    ------
Net income                        $4,593   $2,438    $4,194   $1,622    $1,155
                                  ------   ------    ------   ------    ------
Net income applicable to common 
 stockholders (4)                 $4,492   $1,762    $4,083   $1,622    $1,155
                                  ======   ======    ======   ======    ======

Supplemental pro forma data (5): 
-------------------------------
   Net income                     $4,853   $4,000    $2,955   $1,026      $735
   Net income per common share    $ 0.44   $ 0.37    $ 0.32
   Weighted average common shares
   outstanding                    11,086   10,785     9,334

Operating Data:
--------------
Number of orders                 638,672  429,747   307,525  276,056   247,469
Inventory turnover (6)             11.0x    10.5x     11.8x     9.8x      8.4x
 
Consolidated Balance Sheet Data:
-------------------------------
Working Capital                  $14,410  $ 9,827   $ 7,467  $ 7,838   $ 6,491
Total assets                      41,124   33,130    13,832   12,849    12,248
Long-term debt                         7   34,817    21,830
Redeemable preferred stock  (2)        -    7,437     6,761
Stockholders' equity (deficit)    33,622  (18,047)  (19,926)   9,061     7,868
</TABLE>

                                       10<PAGE>
<PAGE>

--------------------
(1) The Company's fiscal year ends on the Saturday nearest to August 31, and
    is divided into four thirteen-week periods.

(2) In July 1995, the Company effected the Recapitalization, in connection
    with which the Company: (i) issued $6.75 million in aggregate value of
    Summit Notes; (ii) issued $2.5 million in aggregate principal amount of
    Management Notes; (iii) issued $6.65 million in stated value of Redeemable
    Preferred Stock; and (iv) borrowed $13.5 million under the Credit
    Facility. See "Management's Discussion and Analysis of Financial Condition
    and Results of Operations."

(3) Represents bonuses paid to certain executive officers to facilitate their
    purchase of stock prior to the Recapitalization.

(4) Represents net income less the accretion in value of the Redeemable
    Preferred Stock during the period.

(5) Prior to the Recapitalization, the Company elected to be taxed as a
    Subchapter S corporation for federal income tax purposes. Supplemental pro
    forma information has been computed as if the Company had been subject to
    federal income taxes and all applicable state corporation income taxes for
    each period presented. Supplemental pro forma net income and weighted
    average shares also assume, at the beginning of the respective periods,
    the Company had sold, at an offering price of $12.00 per share, shares of
    Common Stock sufficient to fund the Recapitalization in 1995 and repay
    indebtedness incurred in 1996 to finance the acquisition of St. Louis
    Ostomy and Patient-Care.

(6) "Inventory turnover" means the cost of goods sold for the period divided
    by the average inventory balance for the year.

                                       11<PAGE>
<PAGE>
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS
Overview
     
     The Company operates in an environment impacted by cost containment 
efforts and the consolidation of health care companies.  This environment has 
led to the Company's strategic decision to price its products competitively 
and offer volume based pricing programs to its customers.  These factors 
caused the Company to experience some erosion in gross profit as a percentage 
of sales during fiscal 1996.  During fiscal 1997 the Company sought to miti-
gate this decline in gross profit through: (i) the negotiation of volume 
discounts, rebates, promotional allowances and other favorable terms with 
suppliers; and (ii) the regular evaluation of alternate suppliers to obtain 
competitive pricing and quality products.  The gross profit margin was also
affected during fiscal 1997 by the acquisition of Peiser's, Inc. (see Note 3).
Peiser's has a higher gross profit margin than the Company's traditional 
business due primarily to the smaller quantities per order that it ships to 
its customers.  

As a result, the Company's gross profit increased both in absolute dollars 
and as a percentage of sales.  Gross profit increased to  $23.8 million, or 
25.2% for fiscal 1997 versus $17.2 million, or 23.7% for fiscal 1996.  The 
Company believes that cost containment efforts and the consolidation of 
health care companies will continue to exert downward pressure on the Com-
pany's gross profit percentage.  However, the Company believes that the 
utilization of the foregoing programs and the expansion of Peiser's patient-
specific business will mitigate the effects of these pressures such that 
the Company does not expect a significant decrease in its gross profit 
percentage from current levels.  Notwithstanding this belief, there can be 
no assurance that the Company will be able to maintain or increase its level 
of gross profit percentage.

     The Company implemented a business strategy during fiscal 1996, the prin-
cipal components of which were (i) to improve operating income as a percentage
of sales by leveraging its existing infrastructure over a larger base of sales,
(ii) the establishment of budget and expense programs to control expense levels
and (iii) offering incentives for the achievement of cost reduction goals.  The
Company continued to pursue these strategies during fiscal 1997, which enabled 
it to increase operating income by $1.6 million to $8.5 million for fiscal 1997
versus $6.9 million for fiscal 1996.  However, as a percentage of sales, the
Company's operating income decreased from 9.5% for fiscal 1996 to 9.0% for 
fiscal 1997.  The decrease in operating income as a percentage of sales was due 
primarily to two factors: (i) the effect of the UPS strike in the fourth quar-
ter, during which the Company incurred higher freight costs and expenses and a 
reduction in sales volume and (ii) the inclusion of the results of Peiser's 
from May 1, 1997.  Peiser's has a higher operating cost to sales ratio than 
the Company's traditional business due primarily to the fact that their smaller 
per order quantities require a higher degree of labor to pick, pack and ship.

The Company expects to make additional progress in fiscal 1998 in the management
of its operating expenses by streamlining administrative functions, continuing
to offer cost reduction incentives to employees and continuing to invest addi-
tional funds in its MIS infrastructure.  The Company has additional space avail-
able within its current distribution facilities and believes that it can 
increase sales significantly without the need for material investments in 
additional facilities.
                                       12<PAGE>
<PAGE>
Results of Operations

     The following table sets forth for the periods indicated information
derived from the consolidated statements of income of the Company expressed as a
percentage of net sales.  The Company's past operating results are not
necessarily indicative of future operating results.
<TABLE> 
<CAPTION> 
                                             Percentage of Net Sales
                                                   Year Ended
                                 --------------------------------------------
                                 August 30,  August 31,   Sept. 2,    Sept. 3,
                                    1997        1996       1995        1994
                                  -------     -------     -------     -------
<S>                                <C>         <C>         <C>         <C>
Net Sales........................  100.0%      100.0%      100.0%      100.0%
Cost of goods sold...............   74.8        76.3        75.7        75.2
                                   -----       -----       -----       -----
Gross profit.....................   25.2        23.7        24.3        24.8
Operating expenses...............   15.1        13.4        14.7        16.1
Depreciation and amortization....    1.1         0.8         0.5         0.6
Non-recurring executive comp.....      -           -           -         4.7
                                   -----       -----       -----       -----
Operating income.................    9.0         9.5         9.1         3.4
Interest expense.................    0.5         3.7         0.7           -
Other (income) expense, net......   (0.1)       (0.2)       (0.2)       (0.2)
                                   -----       -----       -----       -----
Pre-tax (pro-forma)..............    8.6         6.0         8.6         3.6
Net income (pro-forma)...........    4.8         3.4         5.2         2.2 
</TABLE> 

Years Ended August 30, 1997 (52 weeks) and August 31, 1996 (52 weeks)

     Net Sales increased by $21.9 million, or 30.2%, to $94.4 million for fiscal
1997 versus $72.6 million for the prior year period.  The number of customer
orders filled increased 49% to approximately 639,000 for fiscal 1997 versus
approximately 429,000 for the prior year period.  Of the $21.9 million increase
in net sales for fiscal 1997, approximately 28% was due to the acquisition of
Peiser's, 48% from a full year of sales from Patient-Care, with the balance
coming from growth in sales to existing customers.  Same store growth in net
sales was due primarily to increases in sales to national home health care
chains, MCO's and home health agencies.  The average order size decreased
to $152 for fiscal 1997 versus $173 for the prior year period primarily as a
result of the lower order size of sales made to customers of Peiser's.

     During fiscal 1997, gross profit increased both in absolute dollars and 
as a percentage of sales.  Gross profit increased by $6.7 million, or 39%, to 
$23.8 million for fiscal 1997 versus $17.2 million for the prior year period.  
Gross profit as a percentage of sales increased to 25.2% for fiscal 1997 versus 
23.7% for the prior year period.  The increase in gross profit resulted from 
several ongoing programs including: (i) the negotiation of volume discounts, 
rebates, promotional allowances and other favorable terms with suppliers and 
(ii) the regular evaluation of alternate suppliers to obtain competitive pric-
                                       
                                       13<PAGE>
<PAGE>

ing and quality products.  The gross profit margin was also positively affected 
during fiscal 1997 by the acquisition of Peiser's (see Note 3). Peiser's has 
a higher gross profit margin than the Company's traditional business due pri-
marily to the smaller quantities per order that it ships to its customers.  

     Operating expenses increased by $4.6 million, or 47.5% to $14.3 million 
for fiscal 1997 versus $9.7 million for the prior year period, and as a percen-
tage of net sales, increased to 15.1% for fiscal 1997 versus 13.4% for fiscal 
1996.  Operating expenses increased due primarily to the support required for 
higher sales volume and costs associated with the operations of Peiser's. The 
Company believes that operating expenses as a percentage of net sales will 
decrease during fiscal 1998 as the Company realizes the benefits of several 
initiatives designed to better streamline the Company's infrastructure.

     Depreciation and amortization expense increased by $470,000 or 83.6% to
$1,032,000 for fiscal 1997 versus $562,000 for the prior year period due pri-
marily to the amortization of goodwill associated with the acquisition of 
Peiser's and a full year of amortization of the goodwill associated with the 
acquisitions of St. Louis Ostomy and Patient-Care in fiscal 1996.

     Operating income increased by $1.6 million, or 23.1%, to $8.5 million for
fiscal 1997 versus $6.9 million for the prior year period.  Operating income
decreased as a percentage of net sales to 9.0% for fiscal 1997 versus 9.5% for
the prior year period.  The decrease in operating income as a percentage of
sales was due primarily to the effect of the UPS strike in the fourth quarter,
during which the Company incurred higher freight costs and a reduction in sales
volume.

     Interest expense decreased by $2.2 million, or 83.5%, to $437,000 for 
fiscal 1997 versus $2.7 million for the prior year period.  Interest expense 
decreased due primarily to lower borrowings as a result of the IPO in October 
1996, which was used, in part, to pay off virtually all outstanding debt.

     Income taxes increased by $1.7 million to $3.6 million, or 43.9% of pre-tax
income, for fiscal 1997 versus $1.9 million or 44.4% or pre-tax income, for the
prior year period.  The increase was due primarily to higher operating income in
fiscal 1997 versus fiscal 1996.

 
Years Ended August 31, 1996 (52 weeks) and September 2, 1995 (52 weeks)

     Net Sales increased by $19.9 million, or 37.8%, to $72.6 million for fiscal
1996 versus $52.7 million for the prior year period.  The number of customer
orders filled increased 39.3% to approximately 429,000 for fiscal 1996 versus
approximately 308,000 for the prior year period.  Of the $19.9 million increase
in net sales, aproximately 56% was due to the acquisition of St. Louis Ostomy,
approximately 17% was due to the acquisition of Patient-Care and approximately
27% was due to a 10% growth rate in net sales to existing customers for fiscal
1996.  Same store growth in net sales was due primarily to increases in sales
to national home health care chains and MCO's.  The average order size decreased
to $173 for fiscal 1996 versus $175 for the prior year period primarily as a
result of the lower order size of sales made to customers of St. Louis Ostomy.
                                       
                                       14<PAGE>
<PAGE>
     Gross profit increased by $4.4 million, or 34.4%, to $17.2 million for 
fiscal 1996 versus $12.8 million for the prior year period while gross margin 
decreased to 23.7% for fiscal 1996 versus 24.3% for the prior year period. The 
decrease in gross margin was due primarily to the competitive pricing of pro-
ducts sold by the Company to maintain or increase market share, particularly 
with respect to volume based pricing offered by the Company and the acquisi-
tions of St. Louis Ostomy and Patient-Care.

     Operating expenses increased by $1.9 million, or 24.4% to $9.7 million for
fiscal 1996 versus $7.8 million for the prior year period, and as a percentage
of net sales, decreased to 13.4% for fiscal 1996 versus 14.7% for fiscal 1995.
Operating expenses increased due primarily to the support required for higher
sales volume and costs associated with the operations of St. Louis Ostomy.  The
decrease in operating expenses as a percentage of net sales was due primarily
to the leveraging of the Company's infrastructure over a larger base of sales 
and the effect of Company's established budget and expense programs.

     Depreciation and amortization expense increased by $296,000 or 111.3% to
$562,000 for fiscal 1996 versus $266,000 for the prior year period due primarily
to the amortization of goodwill associated with the acquisitions of St. Louis
Ostomy and Patient-Care.

     Operating income increased by $2.1 million, or 43.8%, to $6.9 million for
fiscal 1996 versus $4.8 million for the prior year period.  Operating income
increased as a percentage of net sales to 9.5% for fiscal 1996 versus 9.1% for
the prior year period.  The increase in operating income as a percentage of net
sales was due primarily to increased sales and the Company's ability to leverage
its existing operating structure over additional sales volume.

     Interest expense increased by $2.3 million, or 621.6%, to $2.7 million for
fiscal 1996 versus $370,000 for the prior year period.  Interest expense in-
creased as a percentage of net sales to 3.7% for fiscal 1996 versus 0.7% for 
the prior year period due primarily to borrowings to fund in part the Recap-
italization, and the acquisitions of St. Louis Ostomy and Patient-Care.

     Income taxes increased by $1.6 million to $1.9 million, or 44.4% of pre-
tax income, for fiscal 1996 versus $358,000, or 7.9% or pre-tax income, for the 
prior year period.  Prior to July 3, 1995, the Company operated as a Subchapter 
S Corporation and was not subject to federal income taxes.  If the Company had 
not elected Subchapter S Corporation status prior to the Recapitalization, the 
Company's proforma income tax expense would have been $1.8 million for fiscal 
1995.

Years Ended September 2, 1995 (52 weeks) and September 3, 1994 (53 weeks)

     Net sales increased by $5.4 million, or 11.3%, to $52.7 million in fiscal
1995 versus $47.3 million in fiscal 1994. The number of customer orders filled
increased 11.6% to approximately 308,000 orders in fiscal 1995 from
approximately 276,000 orders in fiscal 1994. The net sales growth in fiscal 1995
was due primarily to increased sales to independent home health care suppliers
pursuant to volume based pricing programs and increased penetration of national
home health care chains. The average order size remained constant in fiscal 1994
and fiscal 1995 at approximately $176, due to a larger volume of small dollar
amount orders under the Stockless Inventory Program in fiscal 1995 which offset
the effect of price increases and inflation.

                                       15<PAGE>
<PAGE>
     
     Gross profit increased by $1.1 million, or 9.2%, to $12.8 million in fiscal
1995 versus $11.7 million in fiscal 1994, while gross margin decreased to 24.3%
versus 24.8% in fiscal 1994.  The decrease in gross margin was due primarily to
the competitive pricing of products sold by the Company to maintain or increase
market share, particularly with respect to volume based pricing programs offered
by the Company.
 
     Operating expenses increased by $125,000, or 1.6%, to $7.8 million in 1995
versus $7.6 million in fiscal 1994, and as a percentage of net sales, decreased
to 14.7% from 16.1% for the same period.  The decrease in operating expenses as
a percentage of net sales was due primarily to the reduction in compensation
levels related to the Recapitalization.

     There was no non-recurring compensation expense in fiscal 1995, as compared
to non-recurring compensation expense of $2.2 million in fiscal 1994.

     Operating income increased by $3.2 million, or 202.7%, to $4.8 million for
fiscal 1995 versus $1.6 million for fiscal 1994.  The increase in operating 
income was due primarily to the absence of bonus payments of $2.2 million in 
fiscal 1995 and is also due to increased sales and decreased operating expenses 
as a percentage of net sales, offset by declining gross margins.  Excluding the 
effect of the non-recurring compensation, operating income would have increased 
to $4.8 million in fiscal 1995 from $3.8 million in fiscal 1994, representing 
9.1% of net sales in fiscal 1995 and 8.1% of the net sales in fiscal 1994.

     Interest expense for fiscal 1995 was $370,000 due to the incurrence of debt
under the Management Notes, the Summit Notes and the Credit Facility in
connection with the Recapitalization, including $188,000 of interest under the
Management Notes and Summit Notes and $176,000 of interest under the Credit
Facility.

     Income taxes increased by $270,000 to $358,000 in fiscal 1995 from $88,000
in fiscal 1994, representing 7.9% of pre-tax income in fiscal 1995. Prior to
July 3, 1995, the Company operated as a Subchapter S corporation and accordingly
was not responsible for federal and certain state income taxes. If the Company
had not elected Subchapter S corporation status for this period, the Company's
pro forma income tax expense would have been $684,000 and $1.8 million for
fiscal 1994 and fiscal 1995, respectively.

Liquidity and Capital Resources

     Borrowing capacity under the Company's Credit Facility (the "Credit
Facility) is $30 million, and borrowings bear interest at either its lender's
Base Rate or LIBOR plus an applicable margin, depending on the Company's
earnings.  The outstanding borrowings under the Credit Facility are secured by
substantially all of the assets of the Company, including a pledge of all of the
capital stock of its subsidiaries.  The Credit Facility contains covenants which
require the Company to maintain certain financial ratios and impose certain
limitations and prohibitions on the Company with respect to: (i) incurring
additional indebtedness; (ii) the creation of security interests on the assets
of the Company; and (iii) the payment of cash dividends on the Common Stock. 
At August 30, 1997, the Company was in compliance with such covenants.  There
                                       
                                       16<PAGE>
<PAGE>
were no borrowings outstanding under the Credit Facility at August 30, 1997. 
The Company borrowed $3 million on October 10, 1997 for the purpose of 
acquiring Care Management (see Note 12).

     The proceeds of the Company's initial public offering on October 10, 1996
were used to repay in full all outstanding indebtedness of the Company, in-
cluding borrowings under the Credit Facility, retirement of subordinated notes 
issued to certain stockholders and executive officers of the Company and redemp-
tion of the Company's then outstanding Redeemable Preferred Stock. As a result,
after giving effect to the offering and the application of the net proceeds 
therefrom, the Company has no long-term indebtedness, other than amounts which 
the Company may borrow and reborrow under the Credit Facility to fund working 
capital and future acquisitions.

     The Company made capital expenditures totaling $232,000, $315,000 and
$293,000 in fiscal 1997, 1996, and 1995, respectively.  The Company expects to
make total capital expenditures of $1.1 million in fiscal 1998, primarily to 
upgrade and expand its MIS capabilities.  In 1997, the Company began modifying 
its computer system programming to process transactions in the year 2000.  
Anticipated spending for this modification will be expensed as incurred and 
is not expected to have a significant impact on the Company's ongoing results
of operations.

     Other expenses of the Company include the cost of carrying inventory.
During the Company's last five fiscal years, the Company had negligible
inventory write-offs.  Companies which Suburban may acquire may have product
lines or operating assets which are not readily salable, which may lead to
increased inventory write-offs in the future.  At August 30, 1997, the Company
maintained an investment in inventory of approximately $6.6 million.  The
Company's inventory turnover was approximately 11.0 times in fiscal 1997
versus 10.5 times in fiscal 1996 and 11.8 times in fiscal 1995.

     The Company's long-term liquidity needs consist of working capital and
capital required to fund future acquisitions.  The Company believes that its
cash flow from operations and its Credit Facility will be sufficient to fund
its operations and potential acquisitions through fiscal 1998.

Impact of Inflation

     The Company does not believe inflation had a material adverse effect on the
financial statements for the periods presented.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1996

     Forward-looking statements in this report, including without limitation,
statements relating to the Company's plans, strategies, objectives,
expectations, intentions and adequacy of resources, are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of 1996.
Investors are cautioned that such forward-looking statements involve risks and
uncertainties, including without limitation the following: (i) the Company's
plans, strategies, objectives, expectations and intentions are subject to change
at any time at the discretion of the Company; (ii) the Company's plans and
results of operations will be affected by the Company's ability to manage its
growth; and (iii) other risks and uncertainties indicated from time to time in
the Company's filings with the Securities and Exchange Commission.
                                       
                                       17<PAGE>
<PAGE>
 
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

                        SUBURBAN OSTOMY SUPPLY CO., INC.

                         INDEX TO FINANCIAL STATEMENTS


                                                                          Page

  Report of Independent Public Accountants................................ 19

  Consolidated Balance Sheets at August 30, 1997 and August 31, 1996...... 20

  Consolidated Statements of Income for the Years Ended August 30,
     1997, August 31, 1996 and September 2, 1995.......................... 21

  Consolidated Statements of Changes in Stockholders' Equity (Deficit)
     for the Years Ended August 30, 1997, August 31, 1996 and
     September 2, 1995.................................................... 22

  Consolidated Statements of Cash Flows for the Years Ended August 30,
     1997, August 31, 1996 and September 2, 1995.......................... 23

  Notes to Consolidated Financial Statements.............................. 24
 

                                       18<PAGE>
<PAGE>
 
                    REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS


To Suburban Ostomy Supply Co., Inc.:

We have audited the accompanying consolidated balance sheets of Suburban Ostomy
Supply Co., Inc. (a Massachusetts corporation) and subsidiaries as of August 30,
1997 and August 31, 1996, and the related consolidated statements of income,
changes in stockholders' equity (deficit) and cash flows for the years ended
August 30, 1997, August 31, 1996 and September 2, 1995.  These financial state-
ments are the responsibility of the Company's management.  Our responsibility
is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Suburban Ostomy Supply Co.,
Inc., and subsidiaries as of August 30, 1997 and August 31, 1996 and the
results of their operations and their cash flows for the years ended August 30,
1997, August 31, 1996, and September 2, 1995, in conformity with generally
accepted accounting principles.

                                              ARTHUR ANDERSEN LLP


Boston, Massachusetts
October 13, 1997

                                       19<PAGE>
<PAGE>                  SUBURBAN OSTOMY SUPPLY CO., INC.
                           CONSOLIDATED BALANCE SHEET
                   (in thousands, except per share amounts)        
<TABLE>
<CAPTION>
                                       August 30, 1997  August 31, 1996
                                       ---------------  ---------------
<S>                                        <C>             <C>
                                ASSETS
Current Assets
  Cash and cash equivalents                $ 2,270         $ 1,995    
  Accounts receivable, less                             
    allowances of $638 and $416             12,207           8,625   
  Merchandise inventory                      6,611           6,918  
  Prepaid expenses and other                   332             667  
  Deferred income taxes                        464             474  
                                            ------          ------  
     Total current assets                   21,884          18,679  
 
Fixed assets, at cost                        2,967           2,037  
  Less accumulated depreciation             (1,316)           (923)  
                                             -----           -----  
Net fixed assets                             1,651           1,114  
Goodwill                                    17,312          13,039  
Other assets                                   277             298  
                                            ------          ------  
Total assets                               $41,124         $33,130  
                                            ======          ======  
  
            LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities:
  Current maturities of long-term debt      $   16          $  582   
  Accounts payable and accrued expenses      7,608           8,094   
  Income taxes payable                           -             175  
                                             -----           -----  
     Total current liabilities               7,624           8,851  
                                             -----           -----  
Long-term Liabilities:
  Long-term debt, less current maturities        7          24,455  
  Subordinated debt to related parties           -           6,750  
  Notes payable to officers                      -           2,500  
  St. Louis Note payable, less                  
     current portion                             -           1,112   
  Deferred income taxes                         21              71  
                                             -----          ------  
     Total long-term liabilities                28          34,888  
                                             -----          ------  
Redeemable Preferred Stock:
  $.01 par value, $100 redemption value 
     plus 10% cumulative return -
     1,000,000 shares authorized; Issued         
     and outstanding: 0 and 66,500 shares        -           7,437   

Stockholders' Equity (Deficit):
  Common Stock, no par value, 40,000,000 shares
     authorized; Issued and outstanding:
     10,538,503 and 6,223,250 shares at     
     August 30, 1997 and August 31, 1996,
     respectively                           47,188             162 
  Accumulated deficit                      (13,716)        (18,208)
                                            ------          ------  
  Total stockholders' equity (deficit)      33,472         (18,046)  
                                            ------          ------  
Total liabilities and stockholders' 
     equity (deficit)                      $41,124         $33,130  
                                            ======          ======  
</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                       20<PAGE>
<PAGE> 
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                       CONSOLIDATED STATEMENTS OF INCOME
                    (in thousands, except per share amounts)
<TABLE>
<CAPTION>
                                             Year ended
                                        ---------------------
                               August 30,    August 31,    September 2,
                                  1997          1996          1995
                               ----------    ----------    -----------
<S>                             <C>           <C>           <C>
Net sales                       $94,440       $72,558       $52,667    
Cost of goods sold               70,615        55,398        39,873    
                                 ------        ------        ------     
   Gross profit                  23,825        17,160        12,794

Operating expenses               14,291         9,689         7,752    
Depreciation and amortization     1,032           562           266     
                                 ------        ------         -----    
   Operating income               8,502         6,909         4,776    
              
Interest expense                    437         2,653           370
Other income, net                  (127)         (126)         (145)    
                                 ------        ------         -----
   Income before income taxes     8,192         4,382         4,551    
                           
Provision for income taxes        3,599         1,944           357   
                                 ------        ------         -----
   Net income                     4,593         2,438         4,194

Accretion of Preferred Stock        101           676           111   
                                 ------        ------         -----
Net income applicable to 
   common stockholders           $4,492        $1,762        $4,083   
                                  =====         =====         =====


Supplemental Pro Forma (Note 2):                     

   Net income                    $4,853        $4,000        $2,955
                                  =====         =====         =====           

   Net income per share            $.44          $.37          $.32
                                    ===           ===           ===   
   Weighted average common 
   shares outstanding            11,086        10,785         9,334
                                 ======        ======         =====         

The accompanying notes are an integral part of these consolidated financial
statements.
</TABLE>
                                       21<PAGE>
<PAGE>
                       SUBURBAN OSTOMY SUPPLY CO., INC.
     CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
                      (in thousands, except share amounts)
<TABLE>
<CAPTION>
                             Shares of                        Retained    Total 
                              Common     Common   Additional  Earnings  Stockholders'
                             Stock, No  Stock, No   Paid-in (Accumulated  Equity  
                             Par Value  Par Value   Capital  (Deficit)  (Deficit) 
                             --------   ---------   -------   -------    -------   
<S>                          <C>        <C>        <C>      <C>        <C>
Balance, September 3, 1994      22,000  $2,403     $22      $ 6,637    $ 9,061
    
 Shares retired                 (2,000)      -       -       (1,199)    (1,199)
 Dividends on common stock                                                        
  ($110 per share)                   -       -       -       (2,200)    (2,200)     
 Capital contribution                -       -       -          300        300    
 Redemption of 19,880                                                                              
  shares of common stock       (19,880) (2,360)    (22)     (27,690)   (30,071)
 Effect of stock splits      1,859,880       -       -             -         -
 Issuance of 4,340,000
  shares of common stock     4,340,000     100       -             -       100
 Preferred stock accretion           -       -       -          (111)     (111)
 Net income                          -       -       -         4,194     4,194
                             ---------   -----     ---        ------    ------
Balance, September 2, 1995   6,200,000     143       -       (20,069)  (19,926)
 Shares issued under Stock                                                                          
  Option Plan                   23,250      19       -             -        19
 Capital contribution                -       -       -            99        99
 Preferred stock accretion           -       -       -          (676)     (676)
 Net income                          -       -       -         2,438     2,438
                             ---------   -----     ---        ------    ------
Balance, August 31, 1996     6,223,250     162       -       (18,208)  (18,046)
 Initial public offering     4,192,500  46,016                     -    46,016
 Shares issued under Stock                                                                          
  Option Plan                   11,642      10       -             -        10
 Acquisition of Peiser's       111,111   1,000       -             -     1,000
 Preferred stock accretion           -       -       -          (101)     (101)
 Net income                          -       -       -         4,593     4,593
                             ---------   -----     ---        ------    ------
Balance, August 30, 1997    10,538,503  47,188       -       (13,716)   33,472
                            ==========  ======     ===        ======    ======    

</TABLE>

The accompanying notes are an integral part of these consolidated financial
statements.
                                       
                                       22<PAGE>
<PAGE>                  SUBURBAN OSTOMY SUPPLY CO., INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (in thousands)
<TABLE>
<CAPTION>
                                                           Year ended
                                                August 30, August 31, September 2,
                                                   1997       1996      1995
                                                 --------  ---------   ------
<S>                                              <C>       <C>        <C>
Cash Flows from Operating Activities:             
 Net Income                                      $4,492    $2,438     $4,194
 Adjustments to reconcile net income to
  cash provided by operating activities:             
   Depreciation and amortization                  1,032       562        266
   Provision for bad debt losses                    334       439         21
   Net (gain) loss on sale of fixed assets            -       (14)        34
   Deferred income tax benefit, net                 (40)     (274)       (16)
   Change in assets and liabilities net of 
     effects from purchase of St. Louis     
     Ostomy and Patient-Care        
       Accounts receivable                         (966)     (657)      (545)
       Merchandise inventory                      1,115    (1,207)      (577)
       Prepaid expenses and other                   420      (282)        12
       Accounts payable and accrued exps         (1,927)      368        668
                                                  -----     -----      -----
Net Cash provided by operating activities         4,460     1,373      4,057
                                                  -----     -----      -----
Cash Flows from Investing Activities:                          
   Purchase of fixed assets                        (232)     (315)      (294)
   Proceeds from sale of fixed assets                 -       243         10
   Purchase of Peiser's, net of cash acquired    (6,960)        -          -
   Purchase of St. Louis
     Ostomy, net of cash acquired                     -   (10,709)         -
   Purchase of Patient-Care, net of cash acquired     -    (3,403)         -
   Other assets                                    (206)      286        (54)
                                                  -----    ------      -----
Net Cash used in investing activities            (7,398)  (13,898)      (338)
                                                  -----    ------      -----
Cash Flows from Financing Activities:
   Decrease in notes receivable from officers         -       129          -
   Capital contribution from shareholders             -        99        300
   Issuance of common stock                      46,026        19        100
   (Retirement) Issuance of preferred stock      (7,437)        -      6,650
   Dividends paid to stockholders                     -         -     (1,300)
   Repurchase and retirement of common stock          -         -    (28,200)
   Capitalization of financing costs                  -         -       (192)
   Expenses of recapitalization                       -         -       (571)
   Proceeds from issuance of long-term bank 
      debt                                            -    16,467     13,580
   Principal repayments of long-term bank debt  (24,432)   (6,164)    (1,000)
   (Retirement of) Proceeds from 
      issuance of subordinated debt             (10,944)        -      6,750
                                                  -----    ------     ------
Net Cash provided by (used in) financing 
   activities                                     3,213    10,550     (3,883)
                                                  -----    ------     ------
Net (Decrease) Increase in Cash and Cash 
  Equivalents                                       275    (1,975)      (164)
Cash and Cash Equivalents, beginning of year      1,995     3,970      4,134
                                                 ------    ------     ------
Cash and Cash Equivalents, end of year           $2,270    $1,995     $3,970
                                                 ======    ======     ======
</TABLE>
The accompanying notes are an integral part of these consolidated financial
statements.
                                       23<PAGE>
<PAGE>
                         SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(1)  INITIAL PUBLIC OFFERING

     On October 10, 1996, the Company sold 3,900,000 shares or 38.5% of its 
     common stock to the public.  The Company received net proceeds of 
     $43,524,000, after underwriting discounts and commissions of $3,276,000.  
     On October 21, 1996 the underwriter elected to purchase an additional 
     292,500 shares, for which the Company received net proceeds of 
     $3,264,300, net of $245,700 in underwriting discounts and commissions.  
     The sales of common stock increased the outstanding number of shares to 
     10,415,750.  Other expenditures related to the offering reduced the net
     proceeds to the Company to $46,015,714.
     
     Of the total $46,015,714 net proceeds, $42,472,000 was used to pay down 
     certain of the Company's indebtedness and preferred stock.  The Company 
     (i) retired an aggregate of $2,500,000 million in subordinated promissory 
     notes issued to executive officers; (ii) repaid $24,455,000 on its 
     Credit Facility; (iii) redeemed its Redeemable Preferred Stock for 
     approximately $7,437,000; (iv) retired $6,750,000 in subordinated 
     promissory notes issued to Summit; and (v) repaid the St. Louis Note for
     $1,235,000.

(2)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES        
     
     Fiscal Year

     The Company's fiscal year ends on the Saturday nearest to August 31.  
     Fiscal 1997, fiscal 1996 and fiscal 1995 were all 52 week periods.
     
     Use of Estimates

     The preparation of financial statements in conformity with generally
     accepted accounting principles requires management to make estimates and
     assumptions that affect the reported amounts of assets and liabilities and
     disclosure of contingent assets and liabilities at the date of the
     financial statements and the reported amounts of revenues and expenses
     during the reporting period. Actual results could differ from those
     estimates.

     Disclosure of Fair Value of Financial Instruments

     The Company's financial instruments consist mainly of cash and cash
     equivalents, accounts receivable, accounts payable, notes payable and debt.
     The carrying amounts of the Company's cash and cash equivalents, accounts
     receivable and accounts payable approximate fair value due to the short-
     term nature of these instruments. 

                                       24<PAGE>
<PAGE>                  SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(2)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

     Stock Compensation Plans

     At August 30, 1997, the Company has one stock-based compensation plan,
     which is described in Footnote 8 to the Financial Statements.  The Company
     applies APB Opinion 25 and related interpretations in accounting for its
     option grants.  Accordingly, no compensation cost has been charged against
     income for its stock option plan.  Had compensation cost for the Company's
     stock option plan been determined based on the fair value at the grant
     dates for awards under the plan consistent with the method of FASB State-
     ment 123, the Company's net income and earnings per share would have been
     reduced to the pro forma amounts indicated below:

                                                       1997      1996 
                                                       ----      ----   
     Net income                        As reported   $ 4,853    $ 4,000  
                                       Pro forma     $ 4,384    $ 3,987
                                                        
     Primary earnings per share        As reported   $  0.44    $  0.37 
                                       Pro forma     $  0.40    $  0.37
        

     The effects of applying FAS 123 in this proforma disclosure are not
     indicative of future amounts.  The proforma disclosure does not include
     awards anticipated in future years.

     The fair value of each option grant is estimated on the date of grant
     using the Black-Scholes option-pricing model with the following weighted-
     average assumptions used for grants in fiscal 1997 and 1996: dividend 
     yield of zero; expected volatiity of 29%; a risk-free interest rate of 
     6.0%, and expected lives of eight years.

     Merchandise Inventory

     Inventory is stated at the lower of cost or market and is accounted for
     using the weighted moving-average cost method, which approximates the
     first-in, first-out (FIFO) method.

     Fixed Assets

     The cost of property and equipment is depreciated and amortized over the
     estimated useful lives of the related assets, as follows:

          Equipment, computers and fixtures    5-7 years       Straight-line
          Leasehold improvements               4-5 years*      Straight line
           
           (* - or the life of the lease, whichever is shorter)
         
     Repairs and maintenance costs are expensed as incurred.

                                       25<PAGE>
<PAGE>                 
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(2)  SUMMARY OF SIGNIFIGANT ACCOUNTING POLICIES (CONTINUED)

     Long-Lived Assets

     During 1996, the Company adopted the provisions of Statement of Financial
     Accounting Standards No. 121, Accounting for the Impairment of Long-Lived
     Assets (SFAS 121). SFAS 121 requires, among other things, that an entity
     review its long-lived assets and certain related intangibles for impairment
     whenever changes in circumstances indicate that the carrying amount of an
     asset may not be fully recoverable. As a result of its review, the Company
     does not believe that any impairment currently exists related to its long-
     lived assets.

     Goodwill

     The Company has classified as goodwill the cost in excess of fair value of
     the net assets acquired in the purchase of St. Louis Ostomy, Patient-Care 
     and Peiser's (see Note 3). Goodwill is being amortized on a straight-line 
     basis over an estimated useful life not exceeding 25 years.   Accumulated 
     amortization at August 30, 1997 and August 31, 1996 was $900,000 and 
     $277,000, respectively.  The carrying value of goodwill is evaluated when-
     ever events or changes in circumstances indicate that the current useful 
     life has diminished. If undiscounted cash flows over the remaining amorti-
     zation period indicate that goodwill may not be recoverable, the carrying 
     value of goodwill will be reduced.
     
     Cash and Cash Equivalents

     For the accompanying consolidated statements of cash flows, the Company
     considers all highly liquid instruments with original maturities of three
     months or less to be cash equivalents.

     Income Taxes

     Effective July 3, 1995, the Company's tax status changed from a Subchapter
     S corporation to a C corporation, and accordingly, it is subject to federal
     and state income taxes. The Company accounts for taxes in accordance with
     Statement of Financial Accounting Standards No. 109, Accounting for Income
     Taxes (SFAS 109), which is an asset and liability method. Under the asset
     and liability method, deferred taxes are established for the temporary
     differences between the financial reporting and tax bases of the Company's
     assets and liabilities at currently enacted tax laws and rates.

                                       26<PAGE>
<PAGE>                  
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(2)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

     Common Stock Equivalents

     The Common Stock equivalents used to calculate supplemental pro forma 
     net income per share represent, in periods in which they have a dilutive
     effect, the effect of common shares contingently issuable from stock
     options and warrants using the treasury-stock method. Additionally, stock,
     options and warrants issued within one year prior to the filing of the
     Registration Statement (see Note 1) are considered issued and outstanding
     for the periods presented using the treasury stock method.

     Supplemental Pro Forma Net Income Per Share

     Prior to the Recapitalization on July 3, 1995, the Company elected to be
     taxed as a Subchapter S corporation, and accordingly, was not subject to
     federal income taxes and certain state income tax jurisdictions. Further,
     the Company repaid borrowings under the Credit Facility, the Summit Notes,
     the Management Notes, the St. Louis Note and related accrued interest
     thereon with a portion of the net proceeds from the public offering of
     Common Stock on October 10, 1996.

     Supplemental pro forma net income per share for the years ended August 30,
     1997, August 31, 1996 and September 2, 1995 have been calculated (1) as if 
     the Company had been subject to federal and state income taxes for 1996 and
     1995 and (2) as if, at the beginning of the respective periods, the Company
     had sold, at an offering price of $12.00 per share, shares of Common Stock 
     sufficient to fund the July 3, 1995 Recapitalization and repay indebtedness
     incurred in 1996 to finance the acquisitions of St. Louis Ostomy and 
     Patient-Care.

     The weighted average number of shares is the actual weighted average number
     of shares of Common Stock or equivalents thereof outstanding effected for
     the Recapitalization as if it had occurred September 4, 1994, plus (1) for
     the year ended September 2, 1995, the additional shares of Common Stock
     sufficient to fund the Recapitalization (2,450,000) and (2) for the year 
     ended August 31, 1996 the 4,192,500 shares of Common Stock that were sold 
     in connection with the public offering (see Note 1).

                                       27<PAGE>
<PAGE>                  SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(2)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

     Supplemental Pro Forma Net Income Per Share (Continued)
     
     Supplemental pro forma net income per share has been calculated as follows
     (in thousands):
<TABLE>
<CAPTION>
                                                      Year Ended
                                          August 30,  August 31,  September 2,
                                             1997        1996        1995
                                          ---------    --------    ----------
<S>                                       <C>          <C>          <C>
Historical income before taxes            $8,192       $4,383       $4,552
Provision for income taxes                (3,599)      (1,944)      (1,821)
Reversal of interest charges and
   amortization of deferred financing 
   costs relating to debt treated as 
   being repaid, net of tax                  260        1,561          224
                                           -----        -----         ----
Supplemental pro forma net income         $4,853       $4,000       $2,955
                                           -----        -----        -----
Supplemental pro forma net income per
    share                                 $  .44       $  .37       $  .32
                                             ===          ===          ===
Supplemental pro forma weighted 
    average shares outstanding            11,086       10,785        9,334
                                          ======       ======        =====
</TABLE>

     In February 1997, the Financial Accounting Standards Board issued FASB
     Statement No. 128, Earnings Per Share (SFAS 128).  SFAS 128 establishes
     standards for computing and presenting earnings per share and applies to
     entities with publicly traded common stock or potential common stock.  
     SFAS 128 is effective for financial statements for both interim and annual
     periods ending after December 15, 1997 and early adoption is not permitted.
     When adopted, the statement will require the restatement of prior years'
     earnings per share.  The Company will adopt SFAS 128 for its quarter ended
     February 28, 1998.  Assuming SFAS 128 had been implemented, basic earnings
     per share would have been $0.46, $0.40 and $0.34 for fiscal years 1997,
     1996 and 1995, respectively.  Under SFAS 128, diluted earnings per share 
     would not have differed from the net income per share disclosed on the 
     income statement.


     Reclassifications

     Certain reclassifications have been made to the 1995 and 1996 consolidated
     financial statements to conform to the 1997 presentation.

                                       28<PAGE>
<PAGE>
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(3)  ACQUISITIONS

     Fiscal 1996

     On January 22, 1996, the Company acquired all of the outstanding common
     stock of St. Louis Ostomy, a Missouri corporation, for an aggregate
     purchase price, including expenses, of approximately $12,364,000,
     of which $1,235,000 was paid through the issuance of a subordinated
     promissory note (see Note 4). On June 14, 1996, the Company acquired all of
     the outstanding common stock of Patient-Care, a California corporation, for
     an aggregate purchase price, including expenses, of approximately
     $4,200,000, of which $375,000 is payable on the first anniversary of the
     closing, subject to set off (Patient-Care Deferred Payment) (see Note 4).
     The acquisitions were accounted for as purchases and, accordingly, the
     results of operations of St. Louis Ostomy and Patient-Care are included in
     the consolidated financial statements from January 22, 1996 and June 14,
     1996, respectively. The purchase prices were allocated to the net assets
     acquired based on their estimated fair values, which resulted in approxi-
     mately $10,888,000 and $2,435,000 of goodwill for St. Louis Ostomy and 
     Patient-Care, respectively (see Note 2).  The acquisitions were financed 
     using bank debt (see Note 4). 
     
     Fiscal 1997
     
     On May 1, 1997, the Company acquired all of the outstanding common
     stock of Peiser's, an Illinois corporation, for an aggregate
     purchase price, including expenses, of approximately $8,000,000,
     of which $7 million was paid in cash and $1 million in the Company's 
     Common Stock.  The acquisition was accounted for as a purchase and the 
     results of operations of Peiser's are included in the consolidated 
     financial statements from May 1, 1997. The purchase prices were allocated 
     to the net assets acquired based on their estimated fair values, which 
     resulted in approximately $4.9 million of goodwill (see Note 2). The 
     acquisition was financed using cash from operations and investment 
     accounts.  
     
     On an unaudited pro forma basis, assuming Peiser's had been acquired on 
     August 31, 1996, the Company's net sales, net income and earnings per 
     share for fiscal 1997 would have been approximately $106.5 million, $5.1 
     million and $0.49, respectively.  Had the acquisitions of Peiser's, 
     St. Louis Ostomy and Patient-Care all occurred on September 2, 1995 the 
     Company's unaudited pro forma net sales, net income and earnings per 
     share for fiscal 1996 would have been approximately $111.6 million, $2.4 
     million and $0.43, respectively.
     
                                       29<PAGE>
<PAGE>
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(4)    DEBT

     Debt consisted of the following at August 30, 1997 and August 31, 1996

<TABLE>
<CAPTION>
 
                                                     1997      1996
                                                    ------    ------
<S>                                                  <C>      <C>
Secured loans, payable to BankBoston (the Bank), 
    interest rates at August 31, 1996
    ranging from 7.40% to 8.75%                      $  -     $24,428
Summit Notes due June 30, 2000, interest payable 
    quarterly at 12%                                    -       6,750
Management Notes due June 30, 2000, interest 
    payable quarterly at 12%                            -       2,500
St. Louis Note                                          -       1,235
Patient-Care Deferred Payment                           -         375
Equipment capital leases                               23         111
                                                      ---      ------
                                                        -     $35,399
Less: Current Maturities                               16         582
                                                      ---      ------  
                                                     $  7     $34,817
                                                      ===      ======
 </TABLE> 
 
     On July 3, 1995, the Company entered into the Credit Facility with the 
     Bank for $16,000,000. Of the $13,580,000 initial drawdown by the Company,
     $13,500,000 was used to repurchase certain outstanding Common Stock in
     connection with the Recapitalization. During 1996, the Credit Facility 
     was increased by $9,000,000 and $5,000,000 to facilitate the Company's 
     acquisitions of St. Louis Ostomy and Patient-Care, respectively (See Note 
     3.)  In connection with the Credit Facility amendment, the Company pro-
     vided the Bank with warrants to purchase 86,180 shares of the Company's 
     Common Stock at $.81 per share (the Bank Warrant).  The Bank Warrant may 
     also be converted into that number of shares of Common Stock determined 
     by multiplying the number of shares subject to the Bank Warrant (for which 
     the conversion right is being exercised) by a fraction, the numerator of 
     which is the difference between the market price of one share of Common 
     Stock and the per share exercise price of the Bank Warrant, and the de-
     nominator of which is the market price of one share of Common Stock. For 
     purpose of the Bank Warrant, the market price of one share of Common Stock 
     of the Company shall be determined either according to the trading price 
     of the Common Stock during the ten days preceding the exercise of the 
     warrant, or, if the Common Stock does not trade on a national securities 

                                       30<PAGE>
<PAGE>
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997
(4)  DEBT (CONTINUED)

     exchange and is not quoted on the NASDAQ National Market, by agreement 
     between the Company and the Bank.  Should the Company prepay the outstand-
     ing borrowings and terminate the related Credit Facility, the Bank may 
     request that the Company redeem the warrants from the Bank for $90,000. 
     The warrants expire in January 2006. The difference between the $1.61 
     fair value per share of Common Stock at the grant date and the exercise 
     price has been treated as a debt discount and was fully amortized as of 
     August 30, 1997. Advances made under the Credit Facility bear interest 
     at either the Bank's base rate (8.5% at August 30, 1997) or the
     LIBOR rate (5.63% at August 30, 1997) plus an applicable margin.  The
     applicable margin for the LIBOR advances ranges from 1.0% to 1.75% based 
     on the level of the Leverage Ratio as defined in the Credit Facility. 
     Interest is payable monthly in arrears. The average daily unused line 
     bears a commitment fee of .25% per annum payable quarterly.  
     
     The Credit Facility was fully paid down during October 1996 using a portion
     of the proceeds from the public offering (see Note 1).  As of August 30, 
     1997 there no borrowings outstanding under the Facility and the Company
     was in full compliance with all debt covenants.  The total amount of 
     credit available under the Facility at August 30, 1997 was $30 million.
     Subsequent to year end, on October 10, 1997, $3 million was drawn on the 
     Facility to fund the acquisition of Care Management, Inc. (see Note 12).

     On July 3, 1995, the Company issued at face value, the Summit Notes. The
     proceeds were used to fund the Recapitalization.  Also in connection with 
     the Recapitalization, the Company issued the Management Notes for the 
     repurchase of a portion of their outstanding stock. Both the Summit Notes 
     and the Management Notes bear interest at 12% per annum, and were repaid 
     during October 1996 using a portion of the proceeds from the public 
     offering (see Note 1). 

     In connection with the acquisition of St. Louis Ostomy (see Note 3), the
     Company issued the St. Louis Note.  The St. Louis Note was repaid during 
     October 1996 using a portion of the proceeds from the public offering 
     (see Note 1). 

     A portion of the Patient-Care acquisition purchase price (see Note 3) was
     deferred until June 1997. The deferred payment bears interest at 8% per
     annum.  The payment, with interest, was made in June 1997.

                                       31<PAGE>
<PAGE>                   SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997
(5)  INCOME TAXES

     Effective July 3, 1995, the Company's tax status changed from a Subchapter
     S Corporation to a C Corporation, and accordingly, it is subject to federal
     and state income taxes.  Deferred tax assets and liabilities were not
     material at the conversion date.  The Company accounts for taxes in
     accordance with SFAS No. 109, Accounting for Income Taxes, which is an
     asset and liability method.
     The provision (benefit) for income taxes for the years ended August 30,
     1997, August 31, 1996 and September 2, 1995 consisted of the following:
<TABLE>
<CAPTION>
                              1997      1996      1995
                             -----     ------     ----
<S>                          <C>       <C>        <C>
U.S. Federal-   
         Current             $2,610    $1,510     $ 88
         Deferred               (62)      (99)     (12)
State-          
         Current              1,076       584      285
         Deferred               (25)      (51)      (4)
                              -----     -----      ---
                             $3,599    $1,944     $357
                              =====     =====      ===
</TABLE>
     Under SFAS No. 109, net current deferred tax assets or liabilities and net
     long-term deferred tax assets or liabilities are reported separately in the
     Company's balance sheets.  
     The effect of temporary differences which give rise to a significant
     portion of deferred taxes are as follows at August 30, 1997 and August
     31, 1996:
<TABLE>
<CAPTION>
                                                      1997    1996
                                                      ----    ----
<S>                                                   <C>     <C>
Deferred tax assets                      
  Reserves and accruals not yet deductible for tax 
      purposes                                        $412    $408
  Inventory basis differences                           65      62
  Other                                                 19      13
                                                       ---     ---
       Total deferred tax assets                       496     483
                                                       ---     ---
Deferred tax liabilities-                
  Property basis differences                           (35)    (80)
  Other                                                (18)      -
                                                       ---     ---
     Total deferred tax liabilities                    (53)    (80)
                                                       ---     ---
     Net deferred tax assets                          $443    $403
                                                       ===     ===
</TABLE>
                                       32<PAGE>
<PAGE>                  
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(5)  INCOME TAXES (CONTINUED)

     During fiscal 1994, the Company was operating as a Subchapter S Corpora-
     tion and was not subject to federal income taxes. The provision for 
     income taxes in the accompanying statement of operations represents 
     certain state tangible and net worth taxes. A reconciliation of tax on
     income at the federal statutory rate to the recorded income tax provision 
     for fiscal 1997, 1996 and 1995 is presented below:
<TABLE>
<CAPTION>
                                                       1997     1996     1995
                                                      ------   ------   ------
     <S>                                              <C>      <C>      <C>
     Tax provision at statutory rate                  $2,785   $1,490   $1,547
     State tax provision, net of federal taxes           649      352      304
     Subchapter S Corporation earnings not subject
       to federal and state income taxes                   -        -   (1,599)
     Subchapter S Corporation related taxes                -        -      168
     Book expenses not deductible for tax purposes       324      107        -
     Other                                              (159)      (5)     (63)
                                                       -----    -----    -----
            Recorded income tax provision             $3,599   $1,944   $  357
                                                       =====    =====    =====
</TABLE>
(6)  RETIREMENT PLAN

     The Company has adopted a qualified, noncontributory defined contribution
     retirement plan which covers all employees who have completed one year of
     service and who have reached age 21. Employees qualify for benefits upon
     reaching the age of 62, however, an employee cannot receive benefits from
     the defined contribution retirement plan until actual retirement. Vesting
     begins at 20% after two years of employment and is increased by 20% each
     subsequent year until full vesting occurs. Retirement plan contributions
     are made at the discretion of the Company.  During fiscal 1997, 1996 and
     1995 company contributions to the plan were approximately $193,000, 
     $175,000 and $191,000, respectively.

(7)  COMMITMENTS AND CONTINGENCIES

     Leases

     The Company occupies six warehouse facilities and a corporate office
     building (which includes a warehouse) under operating leases expiring at
     various dates through 2006. Two of the warehouses and the Company's
     corporate office and warehouse facility in Holliston, Massachusetts, are
     leased from related parties (see Note 10).

     Certain of the Company's leased premises are subject to renewal options at
     their fair rental values at the time of renewal. Rent expense for fiscal
                                       
                                       33<PAGE>
<PAGE>
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(7)  COMMITMENTS AND CONTINGENCIES (CON'T)
 
     1997, 1996 and 1995, under all operating leases, including certain motor
     vehicle and equipment leases, amounted to approximately $973,000, $810,000
     and $702,000 (net of sublease income of approximately $11,000 and
     $42,000 in fiscal 1996 and 1995), respectively.
     
     At August 30, 1997, approximate future minimum lease payments for the 
     next five years and thereafter under noncancelable operating leases, 
     including $597,000 in each year from 1998 through 2002 and $2,042,000 
     thereafter, to related parties, are as follows:

                   Fiscal Year     Amount

                      1998        $1,098,000
                      1999           877,000
                      2000           885,000
                      2001           793,000
                      2002           677,000
                   Thereafter      2,042,000 
                                  ----------
                                  $6,372,000
                                  ==========

     Employment Contracts

     In connection with the Recapitalization, on July 3, 1995, the Company 
     entered into employment and noncompetition agreements (the Employment 
     Agreements) with five executive officers. The Employment Agreements 
     provide for an employment term through July 1, 2000, after which the term 
     will be automatically renewed on an annual basis unless written notice to 
     the contrary is given at least 90 days in advance by either party. The 
     Employment Agreements provide for an aggregate initial annual base salary 
     of $690,000, subject to such annual increases as may be determined by the 
     Board of Directors, as well as certain benefits and reimbursement of 
     expenses. Should employment be terminated by the Company for any reason 
     other than cause (as defined in the Employment Agreements) the officer 
     shall be entitled to receive all salary and bonus earned through the 
     termination date plus an additional 12 months of salary.
                                       
     Upon the acquisition of Peiser's (see Note 3), the Company executed
     employment agreements with four executives of Peiser's to remain in the 
     employ of the Company.  The agreements have three to five year terms and 
     provide for an annual base salary plus bonuses based on certain perform-
     ance objectives, as well as certain benefits and reimbursement of expenses.
     Should employment be terminated by the Company for any reason other than 
     cause, as defined in the agreements, the officers are entitled to receive 
     all salary and bonuses earned through the termination date plus an 
     additional 12 months of salary.
                                       
                                       34<PAGE>
<PAGE>                    SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(8)  STOCK TRANSACTIONS

     On July 3, 1995, in connection with the Recapitalization, the Company
     adopted an incentive stock option plan (the Stock Option Plan) under
     which 688,820 shares of Common Stock have been authorized. In July 1995,
     the Company granted options to certain officers to purchase a total of 
     620,000 shares of Common Stock.  In October 1995 and March 1997, the
     Company granted to certain employees options to purchase 29,450 and
     17,180 shares, respectively, of Common Stock.  The exercise prices of
     the options granted in July 1995, October 1995 and March 1997 are $0.81,
     $1.61 and $10.63 per share, respectively.  The options vest over seven
     years at rates set forth in the Stock Option Plan agreement and are
     exercisable for a ten year period.

     In addition, the Company granted options to purchase 20,000 shares of 
     Common Stock in April and June 1997 to two Directors.  The exercise 
     prices of these non-qualified stock options are $8.94 and $10.94, 
     respectively.  These options vest over three years and are exerciseable 
     for a ten year period.

     As part of the purchase of Peiser's on May 1, 1997 (see Note 3), the
     Company issued 90,000 options to purchase shares of Common Stock to an
     officer of Peiser's, at an exercise price of $8.97.  The options vest
     over five years and are exerciseable for a ten year period.

     In all option grants, the exercise price is not less than estimated fair
     market value on the grant date.

     A summary of option activity is presented below:
                                                               Weighted Avg
                                                Weighted Avg   Remaining
                                       Shares  Exercise Price  Contractual Life
                                      -------  --------------- ---------------
  Options granted                     620,000       $0.81          

  Outstanding at September 2, 1995    620,000        0.81          9.9 years

     Granted                           29,450        1.61
     Exercised                        (23,250)       0.81 
                                      -------               
  Outstanding, August 31, 1996        626,200        0.84          8.9 years
                                                 
     Granted                          127,180        9.32
     Exercised                        (11,642)       0.85
     Terminated                       ( 5,724)       3.32
                                      -------
  Outstanding, August 30, 1997        736,014        2.29          8.25 years
                                      =======

Options exercisable, August 30, 1997  228,299        0.95
                                      =======   
                                       35<PAGE>
<PAGE>                  
                       SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(9)  STOCK TRANSACTIONS (CONTINUED)   

     The grants made during 1997 have exceeded the amount available under the
     Stock Option Plan as approved by the Stockholders.  At the next Annual
     Meeting of Stockholders of the Company on February 11, 1998, the Board 
     of Directors will recommend approval of, and certain Stockholders of the
     Company have agreed to vote in favor of, a proposal to increase the 
     number of shares authorized, and to include such grants, under the Stock 
     Option Plan.  

     On July 3, 1995, certain stockholders of the Company made a $300,000
     capital contribution pursuant to the Recapitalization, which was used to
     pay a one time bonus to an executive officer of the Company. Payment of the
     bonus was made in 1995 and is included in the operating expenses in the
     accompanying statement of operations.

     In 1995, the Company declared dividends in the amount of approximately
     $2,200,000. In 1996, certain stockholders contributed approximately $99,000
     of this dividend back to the Company. These transactions are reflected in
     the accompanying consolidated statements of changes in stockholders' equity
     (deficit).

(9)  SUPPLEMENTAL CASH FLOW DISCLOSURE 

     Cash payments for interest and income taxes and certain noncash 
     transactions were as follows for the years indicated:

                                                     Year Ended
                                        August 30,  August 31,   September 2,
                                           1997         1996        1995
                                        ----------   --------    ----------
Interest                                 $  437       $2,601      $   51
Income taxes                              3,934        2,147         150
Issuance of subordinated note to 
  acquire net assets of St.Louis Ostomy       -        1,235           -
Issuance of subordinated note to                                       
  acquire net assets of Patient-Care          -          375           -
1996 unpaid dividends contributed by                                      
  stockholders back to the Company            -           99           -
Issuance of 12% note payable on June 30, 
  2000 for repurchase of common stock         -            -       2,500 
Issuance of 200 shares of preferred 
  stock for certain Recapitalization fees     -            -         200
Accretion of preferred stock                101          676         111
Transfer of cash surrender value of life 
  insurance to officers                       -            -         310
Exchange of notes payable by officers 
  for cash surrender value of life
  insurance                                   -            -         235

                                       36<PAGE>
<PAGE>
                        SUBURBAN OSTOMY SUPPLY CO., INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                August 30, 1997

(10) OTHER RELATED PARTY TRANSACTIONS

     The stockholders of the Company and, in certain cases, two of its 
     officers, participate in three partnerships with which the Company has 
     entered into certain transactions. The Company leases warehouse facilities 
     in Holliston, Massachusetts; Atlanta, Georgia; and South Bend, Indiana, 
     from related parties under 15 and 10 year leases expiring in fiscal 2006, 
     2006 and 2003, respectively. Rent expense under these leases amounted to 
     approximately $600,000, $598,000 and $591,000 for 1997, 1996 and 1995, 
     respectively. In the opinion of the Company, the rent paid to related 
     parties is not materially different than the amounts which would be paid 
     to third parties for comparable space. In July 1995, the Company was 
     released from the guarantee of repayment of a mortgage loan on the 
     Atlanta facility.

     In December 1995, the Company sold an automobile with a net book value of 
     $2,000 to one of the executives for $20,000.

(11) LIFE INSURANCE ON KEY EXECUTIVES

     On June 30, 1995, $5,000,000 of life insurance for two key executives 
     which had previously been carried by the Company was transferred back to 
     the executives. In the event of either individual's death, the proceeds 
     of this insurance were to be used to repurchase the individual's stock 
     in the Company at book value. In return for the transfer of the insurance, 
     the executives exchanged certain notes payable to them from the Company and
     issued notes payable of $129,520 in the amount of the difference between
     the old notes payable and the cash surrender value of the insurance plus
     prepaid insurance premiums at the date of transfer.  The entire amount 
     was paid in full by the executives during the year ended August 31, 1996.

(12) SUBSEQUENT EVENTS

     On October 10, 1997 the Company acquired all of the outstanding common
     stock of Care Management, Inc., a Texas corporation, for an aggregate
     purchase price of approximately $3.7 million, which was paid in cash.  
     The acquisition will be accounted for as a purchase and the results of 
     operations of Care Management will be included in the consolidated 
     financial statements of the Company beginning October 10, 1997.  The 
     purchase price has been allocated to the net assets acquired based on 
     their estimated fair values.  The acquisition was financed with cash 
     from operations and by borrowing $3 million from the Credit Facility.
     
                                       37<PAGE>
<PAGE>
 
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURES.

     None.
 
                                   PART III
 
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

ITEM 11. EXECUTIVE COMPENSATION

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

The information required by Items 10, 11, 12 and 13 is hereby incorporated by 
reference from the Registrant's definitive proxy statement for the Annual 
Meeting of Stockholders to be held on February 11, 1998.

 
                                    PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULE, REPORTS ON FORM 8-K.
 
              REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS ON SCHEDULE

 To Suburban Ostomy Supply Co., Inc.:

 We have audited in accordance with generally accepted auditing standards the
 consolidated financial statements as of August 30, 1997, August 31, 1996 and
 September 2, 1995 and for the years then ended, included in Suburban Ostomy
 Supply Co., Inc.'s Form 10-K and have issued our report thereon dated October
 21, 1997. Our audits were made for the purpose of forming an opinion on the
 basic financial statements taken as a whole.  The schedule on the following
 page of this Form 10-K is the responsibility of the Company's management and 
 is presented for purposes of complying with the Securities and Exchange 
 Commission's rules and is not part of the basic financial statements. The 
 schedule has been subject to the auditing procedures applied in the audits
 of the basic financial statements and, in our opinion, fairly states in all
 material respects the financial data required to be set forth therein in
 relation to the basic financial statements taken as a whole.


                                             ARTHUR ANDERSEN LLP

 Boston, Massachusetts
 October 13, 1997

                                      38<PAGE>
<PAGE>
 



               Suburban Ostomy Supply Co., Inc. and Subsidaries

                Schedule II - Valuation and Qualifying Accounts
          For the Period From September 3, 1994 through August 31, 1997
                             (in thousands)
<TABLE>
<CAPTION>

                            Balance at  Charged to        Deductions   Balance at
                             Beginning  Costs and         Write-offs      End
                             of Period  Expenses   Other  of Bad Debt  of Period
                             ---------  ---------  -----  -----------  ----------    
<S>                            <C>         <C>     <C>        <C>       <C>
Year ended September 2, 1995            
   Accounts Receivable         $ 25       $ 21     $  -       $ 21      $ 25
                                ===        ===      ===        ===       ===
Year ended August 31, 1996
   Accounts Receivable         $ 25       $439     $180 (1)   $228      $416
                                ===        ===      ===        ===       ===
Year ended August 30, 1997
   Accounts Receivable         $416       $334     $185 (2)   $297      $638
                                ===        ===      ===        ===       ===

</TABLE>
 
----------------
(1) Represents $104,942 accounts receivable allowance of St. Louis Ostomy
    acquired on January 22, 1996 and $75,297 accounts receivable allowance of
    Patient-Care acquired on June 14, 1996.

(2) Represents $185,000 accounts receivable allowance of Peiser's, Inc.
    acquired on May 1, 1997

                                      39<PAGE>
<PAGE>
 
(a) The following documents are filed as a part of this report:

1.   Financial Statements listed in the index to financial statements on
          page 18 of this report.

2.  Exhibits
 
*3.1    Restated Articles of Organization, as amended of the Company.
*3.2    Amended and Restated Bylaws of the Company
*10.1   Suburban Ostomy Supply Co., Inc. Stock Option Plan
*10.2   Stock Option Agreement with Herbert Grey, dated July 3, 1995
*10.3   Stock Option Agreement with Donald Benovitz, dated July 3, 1995
*10.4   Stock Option Agreement with Stephen N. Aschettino, dated July 3, 1995
*10.5   Stock Option Agreement with John Manos, dated July 3, 1995
*10.6   Employment Agreement with Herbert Gray, dated July 3, 1995
*10.7   Employment Agreement Donald Benovitz, dated July 3, 1995
*10.8   Employment Agreement with Stephen N. Aschettino, dated July 3, 1995
*10.9   Employment Agreement with Patrick Bohan, dated July 3, 1995
*10.10  Employment Agreement with John Manos, dated July 3, 1995
*10.11  $1,000,000 12% Non-Negotiable Subordinated Promissory Note of
            the Company issued to Melvin Aronson, dated July 3, 1995
*10.12  $1,000,000 12% Non-Negotiable Subordinated Promissory Note of
            the Company issued to Melvin Aronson, dated July 3, 1995
*10.13  $375,000 12% Non-Negotiable Subordinated Promissory Note of
            the Company issued to Donald Benovitz, dated July 3, 1995
*10.14  $62,500 12% Non-Negotiable Subordinated Promissory Note of
            the Company issued to Stephen N. Aschettino, dated July 3, 1995
*10.15  $62,50012% Non-Negotiable Subordinated Promissory Note of the
            Company issued to Patrick Bohan, dated July 3, 1995
*10.16  Credit Agreement between the Company and The First National
            Bank of Boston, dated July 3, 1995.
*10.17  First Amendment to Credit Agreement among the Company, the
            Bank and St. Louis Ostomy, dated January 22, 1966.
*10.18  Second Amendment to Credit Agreement among the Company, the
            Bank and St. Louis Ostomy, dated June 14, 1996
*10.19  Proposed terms and conditions of Amended Credit Facility from
            the Bank
*10.20  Warrant to purchase shares of Common Stock issued to the
            Bank, dated January 22, 1996
*10.21  Stock Purchase Agreement relating to the Purchase of St.
            Louis Ostomy by the Company dated January 22, 1996
*10.22  Non-Competition Agreement between the Company and Michael J.
            Quinn, dated January 22, 1996
*10.23  $1,235,000 10% Subordinated Promissory Note of the Company
            issued to Michael J. Quinn, dated January 22, 1996
*10.24  Employment Letter Agreement between the Company and Michael
            J. Quinn, dated January 22, 1996
*10.25  Stock Purchase Agreement relating to the Purchase of
            Patient-Care by the Company, dated June 14, 1996
*10.26  Escrow Agreement among the Company and the Stockholders of
            Patient-Care, dated June 14, 1996

                                      40<PAGE>
<PAGE>

*10.27  Non-Competition Agreement by Nate Spunt for the benefit of
            the Company and Patient-Care, dated June 14, 1996
*10.28  Employment Agreement between Patient-Care and John Somers,
            dated June 14, 1996
*10.29  UPS Ground Incentive Program Contract Carrier Agreement
            between the Company and Patient-Care, dated June 14, 1996
*10.30  Letter Agreement between the Company and UPS, dated August 23, 1995
*10.31  UPS Consignee Billing Contract Courier Agreement between the 
            Company and UPS, dated September 23, 1995

t10.32  Third Amendment to Credit Agreement among the Company, the Bank,
            St. Louis Ostomy and Patient-Care dated October 8, 1996

+10.33  Stock Purchase Agreement relating to the Purchase of
            Peiser's by the Company, dated May 1, 1997
+10.34  Escrow Agreement among the Company and the Stockholders of
            Peiser's dated May 1, 1997
+10.35  Employment Agreement between Peiser's and Barry D. Derman,
            dated May 1, 1997

--------------------
*    Incorporated by reference to the exhibits to the Registration
            Statement No. 333-6621 on Form S-1 filed by the Company with the
            Securities and Exchange Commission

+    Incorporated by reference to the exhibits to the Form 8-K regarding
            the acquisition of Peiser's, Inc. filed with the Securities and
            Exchange Commission in July 1997

t    Attached as part of this Form 10-K


 

(b)   Reports on Form 8-K
            The Company did not file any report on Form 8-K during the last
            quarter covered by this report.
            

                                      41<PAGE>
<PAGE>
                                  SIGNATURES

    Pursuant to the requirements of the section 13 or 15(d) of the Securities 
Exchange Act of 1934, this report has been signed below by the following persons
on behalf of the Registrant and in the capacities and on the dates indicated:

November 25, 1997
                       By:    /s/ HERBERT P. GRAY
                          -------------------------------------------
                              Herbert P. Gray
                              Chief Executive Officer and Director

November 25, 1997
                       By:    /s/ DONALD H. BENOVITZ
                          -------------------------------------------
                              Donald H. Benovitz
                              President and Director

November 25, 1997
                       By:    /s/ STEPHEN N. ASCHETTINO
                          -------------------------------------------
                              Stephen N. Aschettino
                              Vice President, Chief Financial Officer
                              and Treasurer
                              (Principal Financial and Accounting Officer)

November 25, 1997
                       By:    /s/ BARRY D. DERMAN
                          -------------------------------------------
                              Barry D. Derman 
                              President, Peiser's, Inc. and Director

November 25, 1997
                       By:    /s/ MARTIN J. MANNION
                          -------------------------------------------
                              Martin J. Mannion
                              Director

November 25, 1997
                       By:    /s/ JOSEPH F. TRUSTEY
                          -------------------------------------------
                              Joseph F. Trustey
                              Director

November 25, 1997
                       By:    /s/ WILLIAM GREEN    
                          -------------------------------------------
                              William Green
                              Director

November 25, 1997
                       By:    /s/ RICHARD F. BELLOFF
                          -------------------------------------------
                              Richard F. Belloff
                              Director
                 
                                      42<PAGE>